Llwytho...
[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
In the United States, [(68)Ga]Ga-DOTA-TOC has been approved by the Food and Drug Administration (FDA) in 2019 as the first (68)Ga-radiopharmaceutical for imaging of somatostatin receptor (SSTR) positive gastroenteropancreatic neuroendocrine tumors while employing positron emission tomography (PET)....
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pharmaceuticals (Basel) |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7151717/ https://ncbi.nlm.nih.gov/pubmed/32138377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13030038 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|